Person
Ulrich Kaiser
Report
How do drug prices respond to a change from external to internal reference pricing? Evidence from a Danish regulatory reform
Studies the effects of a switch from external reference pricing to internal reference pricing that was implemented in Denmark in April 2005. Abstract We study the effects of a change in the way patient reimbursements are calculated on the prices of pharmaceuticals using quasi-experimental data for Denmark which switched from external (where reimbursements are based...